ArticleHealth affairs (Project Hope)2021
Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment Facilities.
Article in Health affairs (Project Hope), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Impact of Medicaid waivers on medication for opioid use disorders in residential facilities: Evidence from twenty-five states.Drug and alcohol dependence · 2026Article
- Opioid use disorder medication treatment in residential settings increased 2017-2021, but sustaining it following stays remains an issue.Health affairs scholar · 2026Article
- Addressing Psychiatric Bed Capacity: Evidence From Medicaid's Institutions for Mental Disease Waivers for Serious Mental Illness.Health services research · 2026Article
- Medicaid Expansion Boosted Specialty Treatment Episodes For Substance Use Disorder In Expansion States, 2010-22.Health affairs (Project Hope) · 2025Article
- Public Attitudes Toward Mental Health Treatment Policy.JAMA network open · 2025Article
- Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012-22.Health affairs (Project Hope) · 2025Article
- Who Should Respond to Substance-Exposed Infants? Reflections on U.S. Policies Limiting the Role of Child Protective Services.Child protection and practice · 2025Article
- Inpatient psychiatric bed capacity within CMS-certified U.S hospitals, 2011-2023: A cross-sectional study.PLoS medicine · 2025Article
- Private Equity Penetration in Behavioral Health in the United States, 2010-2022.Journal of general internal medicine · 2025Article
- Effects Of Medicaid Waivers On Use Of Medications For Opioid Use Disorder And Nonfatal Overdoses In 17 States.Health affairs (Project Hope) · 2024Article
- The Impact of Medicaid Institutions for Mental Disease Exclusion Waivers on the Availability of Substance Abuse Treatment Services and the Varying Effect by Ownership Type.The Milbank quarterly · 2024Article
- Utilization of Medications for Opioid Use Disorder Among West Virginia Medicaid Enrollees Following Medicaid Coverage of Methadone.Substance use & addiction journal · 2024Article
- Evictions and psychiatric treatment.Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management] · 2024Article
- Changes in institution for mental diseases (IMD) ownership status and insurance acceptance over time.Health affairs scholar · 2024Article
- The effect of cigarette and e-cigarette taxes on prescriptions for smoking cessation medications.Health services research · 2023Article
- Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study.BMC health services research · 2023Article
- Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.JAMA health forum · 2022Article
- Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment.Journal of substance abuse treatment · 2022Article
- Alternative use of buprenorphine among people who use opioids in three U.S. Cities.Substance abuse · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Institutions for Mental Diseases (IMD) exclusion prohibits use of federal Medicaid funds to treat enrollees ages 21-64 in psychiatric residential treatment facilities that have more than sixteen beds. In 2015 the federal government created a streamlined application pathway for state waivers of this rule to allow Medicaid coverage for substance use disorder (SUD) treatment in residential facilities. Nine states received IMD waivers during the period 2015-18. Using data from the 2010-18 National Survey of Substance Abuse Treatment Services, we examined changes in residential and outpatient SUD treatment facilities' acceptance of Medicaid and other types of health coverage, as well as self-pay arrangements and provision of charity care, after states' adoption of IMD waivers. Acceptance of Medicaid increased 34 percent at residential treatment facilities and 9 percent at intensive outpatient facilities two years after waiver implementation. Delivery of medications for opioid use disorder did not increase in residential facilities post waiver but did increase to some extent in outpatient facilities. Our findings suggest that IMD waivers may be an important tool for advancing access to a full continuum of SUD treatment for Medicaid enrollees.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.